Literature DB >> 9217122

Efficacy of tympanomastoid surgery for control of infection in active chronic otitis media.

S N Merchant1, P Wang, C H Jang, R J Glynn, S D Rauch, M J McKenna, J B Nadol.   

Abstract

The efficacy of surgery in controlling infection in 272 tympanomastoidectomy procedures for chronic otitis media (COM) was assessed by means of a four-point rating scale that incorporated both symptoms and signs, such as the presence or absence of otorrhea and granulation tissue. Of the 272 procedures, 170 were performed for COM with cholesteatoma and 102 were for active COM with granulation tissue but no cholesteatoma. Forty-seven percent were primary procedures, and 53% were revisions. Minimum follow-up was 12 months for all cases, with a mean of 30 months. Adequate control of infection occurred in 248 (91%) of the 272 cases. Of the 24 cases (9%) that developed persistent infection, 10 were controlled with a combination of oral and topical antibiotics and/or delayed skin grafting in the office. Thus overall satisfactory control of infection was achieved in 258 of 272 cases (95%). The outcome was influenced by the diagnostic category of COM: COM with cholesteatoma did significantly better than COM with granulation tissue (P = 0.02). The outcome was not influenced by the following variables: primary versus revision surgery, canal wall-up versus canal wall-down surgery, and extent of disease. The results suggest that active COM with granulation tissue may be more difficult to control than COM with cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217122     DOI: 10.1097/00005537-199707000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

1.  Bioactive glass obliteration of the mastoid significantly improves surgical outcome in non-cholesteatomatous chronic otitis media patients.

Authors:  Joris Vos; Pieter de Vey Mestdagh; David Colnot; Pepijn Borggreven; Claudia Orelio; Jasper Quak
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-27       Impact factor: 2.503

2.  Intracranial abscesses associated with chronic suppurative otitis media.

Authors:  Huseyin Seven; Berna Uslu Coskun; Asli B Calis; Ibrahim Sayin; Suat Turgut
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-15       Impact factor: 2.503

3.  Single flap with three pedicles, bone paté and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy.

Authors:  Khaled M Mokbel; Yasser W Khafagy
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-30       Impact factor: 2.503

4.  Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration.

Authors:  Victor J Kroon; Steven W Mes; Pepijn A Borggreven; Rick van de Langenberg; David R Colnot; Jasper J Quak
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-08       Impact factor: 3.236

5.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

6.  A Simple Technique to Obliterate Canal Wall Down Mastoid Cavity Concurrently in Squamosal Otitis Media: Our Experience.

Authors:  Aniket R Buche; Sachin H Garud; Surendra H Gawarle
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-19

7.  Mastoid Obliteration: A Comparison of Two Techniques.

Authors:  N Raadhika Shree; A Ravikumar; Prasanna Kumar Sarvanam
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-03-13

8.  Mid-term outcomes of mastoid obliteration with biological hydroxyapatite versus bioglass: a radiological and clinical study.

Authors:  Sonia Sahli-Vivicorsi; Zarrin Alavi; William Bran; Romain Cadieu; Philippe Meriot; Jean-Christophe Leclere; Rémi Marianowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 3.236

9.  Post-operative healing and long-term stability after mastoid cavity reconstruction using the middle temporal artery and inferior musculoperiosteal flaps.

Authors:  Arthur Dexian Tan; Jia Hui Ng; David Yong-Ming Low; Heng Wai Yuen
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-15       Impact factor: 2.503

10.  Canal wall down mastoidectomy: A long term commitment to the outpatients?

Authors:  Hisham S Khalil; Paul C Windle-Taylor
Journal:  BMC Ear Nose Throat Disord       Date:  2003-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.